These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16673695)

  • 41. Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Benazzi F
    Can J Psychiatry; 2005 Mar; 50(3):184. PubMed ID: 15830829
    [No Abstract]   [Full Text] [Related]  

  • 42. Serotonin syndrome: a complex but easily avoidable condition.
    Dvir Y; Smallwood P
    Gen Hosp Psychiatry; 2008; 30(3):284-7. PubMed ID: 18433663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
    Taylor DM; Cornelius V; Smith L; Young AH
    Acta Psychiatr Scand; 2014 Dec; 130(6):452-69. PubMed ID: 25283309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination of clozapine and maprotiline in refractory psychotic depression.
    Hrdlicka M
    Eur Psychiatry; 2002 Dec; 17(8):484. PubMed ID: 12504267
    [No Abstract]   [Full Text] [Related]  

  • 45. SNRIs in the management of acute major depressive disorder.
    Zajecka JM; Albano D
    J Clin Psychiatry; 2004; 65 Suppl 17():11-8. PubMed ID: 15600377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Venlafaxine and reversible blepharoedema.
    Reif A; Pfuhlmann B
    Int J Neuropsychopharmacol; 2002 Dec; 5(4):413-4. PubMed ID: 12466039
    [No Abstract]   [Full Text] [Related]  

  • 47. An open trial of olanzapine in the treatment of patients with psychotic depression.
    Nelson EB; Rielage E; Welge JA; Keck PE
    Ann Clin Psychiatry; 2001 Sep; 13(3):147-51. PubMed ID: 11791952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine.
    Alpert JE; Papakostas G; Mischoulon D; Worthington JJ; Petersen T; Mahal Y; Burns A; Bottiglieri T; Nierenberg AA; Fava M
    J Clin Psychopharmacol; 2004 Dec; 24(6):661-4. PubMed ID: 15538131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Augmentation with atomoxetine in treatment-resistant depression with psychotic features. A case report.
    Pilhatsch MK; Burghardt R; Wandinger KP; Bauer M; Adli M
    Pharmacopsychiatry; 2006 Mar; 39(2):79-80. PubMed ID: 16555170
    [No Abstract]   [Full Text] [Related]  

  • 50. Delusional wife: a case of diagnostic ambiguity and treatment challenge.
    Ose BL; Pandurangi AK; Gorman JM
    J Psychiatr Pract; 2005 May; 11(3):205-11. PubMed ID: 15920395
    [No Abstract]   [Full Text] [Related]  

  • 51. Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.
    Brent DA; Emslie GJ; Clarke GN; Asarnow J; Spirito A; Ritz L; Vitiello B; Iyengar S; Birmaher B; Ryan ND; Zelazny J; Onorato M; Kennard B; Mayes TL; Debar LL; McCracken JT; Strober M; Suddath R; Leonard H; Porta G; Keller MB
    Am J Psychiatry; 2009 Apr; 166(4):418-26. PubMed ID: 19223438
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sertraline versus venlafaxine XR in major depressive disorder.
    Lusicic A; Jagadheesan K
    J Clin Psychiatry; 2007 Oct; 68(10):1618-9; author reply 1619. PubMed ID: 17960983
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of sertraline on risk of falling in older adults with psychotic depression on olanzapine: results of a randomized placebo-controlled trial.
    Flint AJ; Iaboni A; Mulsant BH; Rothschild AJ; Whyte EM; Meyers BS;
    Am J Geriatr Psychiatry; 2014 Apr; 22(4):332-6. PubMed ID: 23642462
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinically relevant pharmacokinetic interaction between venlafaxine and bupropion: a case series.
    Paslakis G; Gilles M; Deuschle M
    J Clin Psychopharmacol; 2010 Aug; 30(4):473-4. PubMed ID: 20631572
    [No Abstract]   [Full Text] [Related]  

  • 55. Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patients.
    Sharpley AL; Attenburrow ME; Hafizi S; Cowen PJ
    J Clin Psychiatry; 2005 Apr; 66(4):450-4. PubMed ID: 15816787
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
    Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
    J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics.
    Khouzam HR
    Postgrad Med; 2016; 128(3):323-30. PubMed ID: 26821680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features.
    Rothschild AJ; Williamson DJ; Tohen MF; Schatzberg A; Andersen SW; Van Campen LE; Sanger TM; Tollefson GD
    J Clin Psychopharmacol; 2004 Aug; 24(4):365-73. PubMed ID: 15232326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
    Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Steroid responsive psychotic depression.
    Dickmann JR; Eversheim F
    Aust N Z J Psychiatry; 2009 Jul; 43(7):690-1. PubMed ID: 19536916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.